Question of the Day – Thursday February 21, 2019
Question - What is an “essential oil”?
Question of the Day – Wednesday February 20, 2019
Question - How does OSHA define a recordable illness or injury?
Question of the Day – Tuesday February 19, 2019
Question - What are the so-called “BTEX” chemicals?
Question of the Day – Monday February 18, 2019
Question - Injection-associated anthrax due to drug injection has been reported. How does cutaneous anthrax differ from injectional anthrax?
Question of the Day – Wednesday February 13, 2019
Question - The perfluoroalkyl compounds PFOA and PFOS are no longer manufactured or imported into the United States. What has happened to serum levels of these compounds in the general U.S. population, in part, as a result of the discontinuation of manufacture and importation of these chemicals?
Question of the Day – Tuesday February 12, 2019
Question - The abuse of opium is widespread in some countries including Iran and Afghanistan. Opium samples from these regions are often adulterated. What substances have been reported as adulterants for opium in these countries?
Question of the Day – Monday February 11, 2019
Question -The so-called “red man syndrome” (RMS) is a recognized adverse reaction that may occur in patients receiving vancomycin. What are the risk factors for the development of red man syndrome specifically in pediatric patients?
Question of the Day – Friday February 8, 2019
Question - The article cited below notes that xylazine “is marketed as a veterinary drug and used as a sedative, analgesic and muscle relaxant. In humans, it could cause central nervous system depression, respiratory depression, bradycardia, hypotension, and even death.” This substance has been used to adulterate a variety of street drugs including heroin and cocaine. What is the mechanism of action of xylazine?